TGFB1 and breast carcinoma: In concurrence, TGF‐β neutralization in a subcutaneous 4T1 implantation model of breast cancer led to diminished myCAFs, enhanced CD8+ T‐cell infiltration, and augmented anti‐PD1 response [52].